ctrl K

Watchlist Price Alert

Neoleukin Therapeutics In... (NLTX)

NASDAQ: NLTX · Real-Time Price · USD

3.49

0.05 (1.45%)

At close: Dec 18, 2023, 9:00 PM

Neoleukin Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	n/a	6K	451K	n/a	25M	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	6K	451K	n/a	25M	n/a	n/a
Operating Income	-59.1M	-60.7M	-33.73M	-70.96M	-32.62M	-51.12M	-37.65M
Interest Income	1.58M	19K	490K	1.54M	1.56M	998K	619K
Pretax Income	-57.56M	-60.69M	-33.28M	-69.44M	-31.59M	-50.18M	-37M
Net Income	-56.02M	-58.41M	-24.96M	-69.44M	-31.59M	-50.18M	-37M
Selling & General & Admin	17.97M	21.54M	17.21M	18.83M	15.84M	14.85M	9.26M
Research & Development	41.13M	39.16M	24.34M	4.42M	41.79M	36.27M	28.38M
Other Expenses	-42K	6K	-44K	-8K	-445K	-39K	-43K
Operating Expenses	59.1M	60.7M	41.55M	23.24M	57.62M	51.12M	37.65M
Interest Expense	1.58M	n/a	n/a	1K	4K	4K	1K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	59.1M	60.7M	41.55M	23.24M	57.62M	51.12M	37.65M
Income Tax Expense	-1.54M	-2.28M	-8.32M	-7K	-1.04M	-940K	-644K
Shares Outstanding (Basic)	11.04M	11.01M	10.37M	5.41M	4.7M	4.69M	3.78M
Shares Outstanding (Diluted)	11.04M	11.01M	10.37M	5.41M	4.7M	4.69M	3.78M
EPS (Basic)	-1.01	-1.06	-0.48	-2.57	-1.34	-2.14	-1.96
EPS (Diluted)	-1.01	-1.06	-0.48	-2.57	-1.34	-2.14	-1.96
EBITDA	-56.48M	-60.7M	-47.56M	-21.37M	-31.51M	-50.16M	-37.07M
EBIT	-55.98M	n/a	n/a	-69.44M	-31.58M	-51.17M	-37M
Depreciation & Amortization	2.61M	2.28M	-13.84M	49.59M	1.04M	940K	644K